The transition to personalized medicine: the role of pharmacogenetics
Conflicts of Interest Disclosure:
The authors declares that there is no conflict of interest.
Article info:
Date submitted: 16.06.2024
Published: 16.06.2024
The author has read and approved the final manuscript.
Peer review info:
"Pharmacogenetics and Pharmacogenomics" thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Editorial comment:
In case of any discrepancies in a text or the differences in its layout between the pdf-version of an article and its html-version the priority is given to the pdf-version.
About the Author
D. A. Sychev
Российская медицинская академия непрерывного профессионального образования Министерства здравоохранения Российской Федерации
Russian Federation
Sychev D. A. - Editor-In-Chief
For citations:
Sychev D.A.
The transition to personalized medicine: the role of pharmacogenetics. Pharmacogenetics and Pharmacogenomics. 2024;(1):4.
(In Russ.)
Views:
423